Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young and
middle‐aged women. It usually lasts for several years (> 1 year in 25–75% of patients) and …

Background and objectives Urticaria is a frequent skin condition, but reliable prevalence
estimates from population studies particularly of the chronic form are scarce. The objective of …

This update on chronic urticaria (CU) focuses on the prevalence and pathogenesis of
chronic spontaneous urticaria (CSU), the expanding spectrum of patient-reported outcome …

To cite this article: Maurer M, Weller K, Bindslev‐Jensen C, Giménez‐Arnau A, Bousquet PJ,
Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CEH, Greaves MW, Hide M …

The current therapeutic algorithm for chronic spontaneous urticaria (CSU), endorsed by the
international guideline, entails treatment escalation from second‐generation H1 …

This guidance for the management of patients with chronic urticaria and angioedema has
been prepared by the Standards of Care Committee of the British Society for Allergy and …

This guideline, together with its sister guideline on the management of urticaria [Zuberbier T,
Asero R, Bindslev‐Jensen C, Canonica GW, Church MK, Giménez‐Arnau AM et al …

BACKGROUND: Proof-of-concept studies with omalizumab in patients with chronic
idiopathic urticaria (CIU) have shown significant decreases in mean urticaria activity scores …

This is Part 1 of an updated follow-up review of a World Allergy Organization (WAO) position
paper published in 2012 on the diagnosis and treatment of urticaria and angioedema. Since …

Injection of autologous serum collected during disease activity from some patients with
chronic spontaneous urticaria (CU) into clinically normal skin elicits an immediate weal and …